Table 2.
Gender-specific burden of thyroid cancer attributable to high BMI globally and in China in 1990 and 2021.
| Variable | DALYs number | Cude DALY rate(per 100,000) | ASDR (per 100,000) | Deaths number | Cude death rate(per 100,000) | ASMR(per 100,000) |
|---|---|---|---|---|---|---|
| Global Male | ||||||
| 1990(n, 95%%UI) | 20879 (15682, 26681) |
0.78 (0.58, 0.99) |
1.06 (0.79, 1.36) |
704 (515, 901) |
0.03 (0.02, 0.03) |
0.04 (0.03, 0.05) |
| 2021(n, 95%%UI) | 56835 (42680, 73440) |
1.44 (1.08, 1.85) |
1.38 (1.04, 1.79) |
2029 (1510, 2596) |
0.05 (0.04, 0.07) |
0.05 (0.04, 0.07) |
| Global Women | ||||||
| 1990(n, 95%%UI) | 40936 (31059, 52907) |
1.55 (1.17, 2) |
1.87 (1.42, 2.41) |
1494 (1117, 1923) |
0.06 (0.04, 0.07) |
0.07 (0.05, 0.09) |
| 2021(n, 95%%UI) | 88120 (64992, 114469) |
2.24 (1.65, 2.91) |
1.96 (1.44, 2.55) |
3225 (2329, 4164) |
0.08 (0.06, 0.11) |
0.07 (0.05, 0.09) |
| China Male | ||||||
| 1990(n, 95%%UI) | 2690 (1748, 4106) |
0.44 (0.29, 0.68) |
0.62 (0.4, 0.95) |
88 (57, 134) |
0.01 (0.01, 0.02) |
0.03 (0.02, 0.04) |
| 2021(n, 95%%UI) | 12278 (7558, 17839) |
1.69 (1.04, 2.45) |
1.25 (0.77, 1.8) |
455 (281, 653) |
0.06 (0.04, 0.09) |
0.05 (0.03, 0.07) |
| China Women | ||||||
| 1990(n, 95%%UI) | 5577 (3671, 7973) |
0.98 (0.64, 1.4) |
1.21 (0.79, 1.71) |
187 (123, 265) |
0.03 (0.02, 0.05) |
0.04 (0.03, 0.06) |
| 2021(n, 95%%UI) | 11407 (7183, 16975) |
1.64 (1.03, 2.44) |
1.07 (0.67, 1.6) |
416 (265, 603) |
0.06 (0.04, 0.09) |
0.04 (0.02, 0.06) |
DALYs, disability-adjusted life-years; n, number; UI, uncertainty interval; ASDR, age-standardized DALY rate; ASMR, age-standardized mortality rate.